Publication | Closed Access

pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer

NanomedicineNeck CancerEngineeringPolymer-drug ConjugateMedicineSrc InhibitorNano-drug DeliveryHead And Neck CancerTumor TargetingAnti-cancer AgentPh-responsive NanoprodrugsPharmacologyTreatment ResistanceCancer ResearchBiomolecular Engineering